AMP Amplifon S.p.A.
Amplifon S.p.A. distributes hearing solutions and the fitting of customized products that helps people to rediscover various emotions of sound in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. It operates Ampli-care, a platform to deliver audiological care experience; and Amplifon App to manage the device functions in real-time directly from smartphone. The company also offers Ampli-power and Ampli-mini hearing devices. Amplifon S.p.A. was founded in 1950 and is headquartered in Milan, Italy.…
Industry Peers
Medical DistributionKey Statistics
About Amplifon (BIT: AMP)
›
Amplifon (BIT: AMP) is listed on Borsa Italiana, where its shares trade in EUR. It belongs to the Medical Distribution industry, part of the Healthcare sector, and reports about 11,792 employees.
The shares were at 11.22 EUR on 19 November 2026, down 17.8% over 52 weeks. Its 52-week range is 7.836 EUR to 14.39 EUR: the price is 22.0% below the high and 43.2% above the low.
At a market capitalisation of 2.98B EUR, it trades at 36.2 times trailing earnings and 12.5 times forward earnings. The median trailing P/E of its 17 largest Medical Distribution peers is 20.3, a premium of 79% for AMP. It pays a dividend yielding 2.55% (it pays out 93% of its earnings), against a median of 1.38% among the dividend payers in that peer group.
Amplifon reports return on equity of 9.1%, an operating margin of 10.7% and revenue up 2.1% year over year.
Its debt exceeds its cash by 1.07B EUR, a debt-to-equity ratio of 1.82. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 17 analysts cover the stock, with an average rating of Buy; their mean price target of 14.21 EUR is 26.6% above the current price. The next earnings report is expected on 4 March 2027.